Does immunotherapy for treatment of reproductive failure enhance live births?
about
'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic eraThe Uterine Immune Profile May Help Women With Repeated Unexplained Embryo Implantation Failure After In Vitro FertilizationAdd-ons in IVF programme - Hype or Hope?Recurrent implantation failure: the role of the endometrium.Intralipid Infusion is the Current Favorite of Gynecologists for Immunotherapy.Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?Pre-Pregnancy Levels of Peripheral Natural Killer Cells as Markers for Immunomodulatory Treatment in Patients with Recurrent Miscarriage.Consecutive successful pregnancies subsequent to intravenous immunoglobulin therapy in a patient with recurrent spontaneous miscarriagePravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).Preimplantation and postimplantation therapy for the treatment of reproductive failure.Successful Pregnancy Outcome in Women with Recurrent IVF Failure and Anti-hCG Autoimmunity: A Report of Three CasesPreimplantation genetic diagnosis: recent triumphs and remaining challenges.Adaptive immune responses during pregnancy.Mouse is the new woman? Translational research in reproductive immunology.Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion.Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells.A blessing and a curse: is high NK cell activity good for health and bad for reproduction?Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.Is superfertility associated with recurrent pregnancy loss?Commentary on current trends of reproductive immunology practices in IVF: a first world survey using IVF-worldwide.com.NK cell abnormality and its treatment in women with reproductive failures such as recurrent pregnancy loss, implantation failures, preeclampsia, and pelvic endometriosis.The role of immunological testing and intervention in reproductive medicine: A fertile collaboration?The frequency of clinical pregnancy and implantation rate after cultivation of embryos in a medium with granulocyte macrophage colony-stimulating factor (GM-CSF) in patients with preceding failed attempts of ART.Chronic endometritis in patients with unexplained infertility: Prevalence and effects of antibiotic treatment on spontaneous conception.IL-10 gene promoter and intron polymorphisms and changes in IL-10 secretion in women with idiopathic recurrent miscarriage.Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050).ART implantation failure and miscarriage in patients with elevated intracellular cytokine ratios: response to immune support therapy
P2860
Q24289157-45BF1913-3D87-42CE-AC24-3649D5B593B1Q26771571-02006CAE-C81A-4B63-BFAC-7CBD82A5407BQ28075629-E6487901-AC8F-4F32-976E-2561594796A2Q34490696-25BE817C-4A97-4FD6-854F-8348576B6CABQ35897639-E168658D-3715-4FD1-8080-15DA618B1B0BQ35915182-3A0724A9-175D-49B4-B610-5839999B8B1EQ36304935-C0C1F174-7A9F-4E19-85AF-FE16CA64E6E9Q36390989-939698AE-1540-4BAE-A2C9-956E02C9F9A7Q36455584-FF55A669-A307-426B-BAB0-E4CF8E8357B8Q36697714-B8623E8E-E1DF-4F4B-978D-2BCB065326D5Q37186650-6334A032-6FE0-40A9-85B0-45680C9E45E3Q37483349-2C294610-DE5B-4FBB-A5A6-F81062BDB71BQ38030601-3029F1DD-799D-47DF-97C7-693720AF4E09Q38082526-8C0E9457-29A1-46EA-B83B-89A2FF1ACCC9Q38701730-4338F7A5-EF71-46AB-8736-F46F5FFB4A3BQ38811579-0A1F867E-688B-4176-93AE-6EFAD601B02BQ38960504-EB81E382-7363-49AE-A3AF-BDABDF4BC21CQ38962831-40356553-AC8B-4D4E-9752-6B1D2F5B71D3Q39235290-C8DCD8FF-E9B6-4D30-A552-907B276A0A41Q44127774-F8DFD16D-DE2C-4A77-B779-31A3858384E9Q45948493-B3A30195-A927-49A7-920E-D17297512930Q47145348-D5310FE8-D0A6-4C21-BB99-DF1D35517479Q47445746-65E514F0-4493-410A-BF6A-2E245133D94AQ47835858-BDF7FF9C-EB96-4026-82F1-3C29960B2A95Q48308425-C8B0381F-4066-430A-8CF5-C4A969FA4F04Q50710641-6DD2D44E-53C1-401C-9A3A-E65924B3DE7CQ52906269-AF529CA2-BFA3-46C4-963E-904CC3154034Q54957684-CF0757D6-211F-4169-AC82-4C4547CA4611Q57813347-84788391-59F1-4F9D-A1A2-EB5E604EC9F7
P2860
Does immunotherapy for treatment of reproductive failure enhance live births?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Does immunotherapy for treatment of reproductive failure enhance live births?
@en
Does immunotherapy for treatment of reproductive failure enhance live births?
@nl
type
label
Does immunotherapy for treatment of reproductive failure enhance live births?
@en
Does immunotherapy for treatment of reproductive failure enhance live births?
@nl
prefLabel
Does immunotherapy for treatment of reproductive failure enhance live births?
@en
Does immunotherapy for treatment of reproductive failure enhance live births?
@nl
P2860
P1476
Does immunotherapy for treatment of reproductive failure enhance live births?
@en
P2093
Brian Acacio
Carolyn B Coulam
P2860
P304
P356
10.1111/J.1600-0897.2012.01111.X
P577
2012-02-16T00:00:00Z